Richard Nieman - 11 Jul 2022 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Chief Medical Officer
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Richard Nieman
Issuer symbol
LYRA
Transactions as of
11 Jul 2022
Net transactions value
$0
Form type
3
Filing time
12 Jul 2022, 16:05:12 UTC
Next filing
02 Feb 2023
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.